Publications

  1. Panch SR, Vassallo RR, Adams S, Borge DP, Gammon R, Gandhi MJ, Philogene M, Sullivan HC, Wu Y, Kopko P. Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review. Transfusion. 2024 Dec; 64 (12):2380-2390 Epub 2024 Oct 27
    View PubMed
  2. Agrawal A, Balakrishnan S, Gandhi MJ, Alexander MP, Cornell L, Bentall AJ, Kukla A, Stegall M, Schinstock CA. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study. Transplantation. 2024 Sep 1; 108 (9):1986-1993 Epub 2024 Aug 20
    View PubMed
  3. Sullivan HC, Borge PD Jr, Gammon RR, Gandhi M, Philogene MC, Wu Y, Kopko PM. Advances in Human Leukocyte Antigen Testing Technologies and Management Strategies for Platelet Transfusion Refractoriness. Arch Pathol Lab Med. 2024 Jun 14 Epub 2024 June 14
    View PubMed
  4. Pena JRA, Fung MK, Gandhi MJ. A Review of Laboratory Practices Using the HLA-B27 Survey by the College of American Pathologists: How Important Is Allele-Level Typing? Arch Pathol Lab Med. 2024 Feb 1; 148 (2):149-154
    View PubMed
  5. Cushman-Vokoun A, Schmidt RJ, Hiemenz MC, Fung M, Zhang BM, Bradshaw G, Gandhi M, Yao J, Yohe S, Beckman A, Grody WW, Giannikopoulos P. A Primer on Gene Editing: What Does It Mean for Pathologists? Arch Pathol Lab Med. 2023 Aug 23 [Epub ahead of print]
    View PubMed
  6. Cushman-Vokoun A, Schmidt RJ, Hiemenz MC, Fung M, Zhang BM, Bradshaw G, Gandhi M, Yao J, Yohe S, Beckman A, Grody WW, Giannikopoulos P. A Primer on Gene Editing. Arch Pathol Lab Med. 2023 Aug 22 [Epub ahead of print]
    View PubMed
  7. Moyer AM, Hashmi SK, Kroning CM, Patnaik M, Litzow M, Gastineau DA, Hogan WJ, Jacob EK, Kreuter JD, Wakefield LL, Gandhi MJ. Clinical impact of KIR haplotypes in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2023 Mar; 64 (3):671-678 Epub 2022 Nov 30
    View PubMed
  8. Sullivan HC, Gandhi MJ, Gaitonde S, Narasimhan R, Gendzekhadze K, Pandey S, Roby RK, Maha GC, Kaur H, Schiller JJ, McDowell J, Smith M, Liu C, Morris GP. Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing. Front Genet. 2023; 14:1331169 Epub 2023 Dec 19
    View PubMed
  9. Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Orti G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022 Apr; 28 (4):187.e1-187.e10 Epub 2022 Jan 23
    View PubMed
  10. Merzkani MA, Bentall AJ, Smith BH, Benavides Lopez X, D'Costa MR, Park WD, Kremers WK, Issa N, Rule AD, Chakkera H, Reddy K, Khamash H, Wadei HM, Mai M, Alexander MP, Amer H, Kukla A, El Ters M, Schinstock CA, Gandhi MJ, Heilman R, Stegall MD. Death With Function and Graft Failure After Kidney Transplantation: Risk Factors at Baseline Suggest New Approaches to Management. Transplant Direct. 2022 Feb; 8 (2):e1273 Epub 2022 Jan 13
    View PubMed
  11. Moyer AM, Gandhi MJ. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics. Methods Mol Biol. 2022; 2547:21-45
    View PubMed
  12. Juskewitch JE, Zuccarelli MD, Clymer KK, Wakefield LL, Kreuter JD, Gandhi MJ. Prozone rates in the solid-phase platelet crossmatch assay and correlation with class I HLA antibody levels. Transfusion. 2021 Nov; 61 (11):3236-3246 Epub 2021 Sept 15
    View PubMed
  13. D'Costa MR, Bentall A, Denic A, Schinstock CA, Merzkani MA, Park WD, Ryan MS, Alexander MP, Smith BH, Gandhi MJ, Stegall MD. Chronic Histologic Changes Are Present Regardless of HLA Mismatches: Evidence from HLA-Identical Living Donor Kidney Transplants. Transplantation. 2021 Nov 1; 105 (11):e244-e256
    View PubMed
  14. Berchtold L, Letouze E, Alexander MP, Canaud G, Logt AV, Hamilton P, Mousson C, Vuiblet V, Moyer AM, Guibert S, Mrazova P, Levi C, Dubois V, Cruzado JM, Torres A, Gandhi MJ, Yousfi N, Tesar V, Viklicky O, Hourmant M, Moulin B, Rieu P, Choukroun G, Legendre C, Wetzels J, Brenchley P, Ballarin Castan JA, Debiec H, Ronco P. Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685. Kidney Int. 2021 Jul; 100 (1):243
    View PubMed
  15. Wen J, Basu A, Bentall A, Henderson N, Dukek B, Gandhi M, Schinstock C. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody? Hum Immunol. 2021 Apr; 82 (4):240-246 Epub 2021 Feb 20
    View PubMed
  16. Daly RC, Rosenbaum AN, Dearani JA, Clavell AL, Pereira NL, Boilson BA, Frantz RP, Behfar A, Dunlay SM, Rodeheffer RJ, Schirger JA, Taner T, Gandhi MJ, Heimbach JK, Rosen CB, Edwards BS, Kushwaha SS. Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients. J Am Coll Cardiol. 2021 Mar 16; 77 (10):1331-1340
    View PubMed
  17. Berchtold L, Letouze E, Alexander MP, Canaud G, Logt AV, Hamilton P, Mousson C, Vuiblet V, Moyer AM, Guibert S, Mrazova P, Levi C, Dubois V, Cruzado JM, Torres A, Gandhi MJ, Yousfi N, Tesar V, OndrejViklicky OndrejViklicky, Hourmant M, Moulin B, Rieu P, Choukroun G, Legendre C, Wetzels J, Brenchley P, Ballarin Castan JA, Debiec H, Ronco P. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021 Mar; 99 (3):671-685 Epub 2020 Sept 02
    View PubMed
  18. Juskewitch JE, Zuccarelli MD, Berg HE, Summerfield DD, Wakefield LL, Gandhi MJ. Transfusion medicine illustrated: When less is more for HLA antibodies. Transfusion. 2021 Jan; 61 (1):9-11 Epub 2020 Aug 24
    View PubMed
  19. Baig NA, Dukek BA, Falbo DK, Wakefield LL, DiGuardo MA, Bobr A, Kreuter JD, Gandhi MJ. Daratumumab interference in flow cytometric anti-granulocyte antibody testing can be overcome using non-human blocking antibodies. Vox Sang. 2021 Jan; 116 (1):116-122 Epub 2020 Aug 14
    View PubMed
  20. Horton RK, Zuccarelli MD, Wakefield LL, DiGuardo MA, Gandhi MJ, Juskewitch JE. False-negative solid-phase platelet crossmatch results due to prozone phenomenon. Transfusion. 2020 Dec; 60 (12):3055-3059 Epub 2020 Oct 13
    View PubMed
  21. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
    View PubMed
  22. Kotwal A, Gustafson MP, Bornschlegl S, Kottschade L, Delivanis DA, Dietz AB, Gandhi M, Ryder M. Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations. Thyroid. 2020 Oct; 30 (10):1440-1450 Epub 2020 May 21
    View PubMed
  23. Juskewitch JE, Gandhi MJ, Kreuter JD, Norgan AP. Development and performance characteristics of Platelet Virtual Crossmatch (PLT VXM), a software application for the evaluation and management of platelet transfusion-refractory patients. Transfusion. 2020 Oct; 60 (10):2284-2293 Epub 2020 Aug 21
    View PubMed
  24. Moyer AM, McMillin GA, Long TA, Gandhi MJ, Mao R, Smock KJ, Halley JG, Weck KE. Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing. Arch Pathol Lab Med. 2020 Sep 1; 144 (9):1057-1066
    View PubMed
  25. Moyer AM, Dukek B, Duellman P, Schneider B, Wakefield L, Skierka JM, Avula R, Bhagwate AV, Kalari KR, Kreuter JD, Goetz MP, Boughey JC, Black JL 3rd, Gandhi MJ. Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type. Hum Immunol. 2020 Aug; 81 (8):423-429 Epub 2020 June 13
    View PubMed
  26. Enninga EAL, Leontovich AA, Fedyshyn B, Wakefield L, Gandhi M, Markovic SN, Ruano R, Kerr SE. Upregulation of HLA-Class I and II in Placentas Diagnosed with Villitis of Unknown Etiology. Reprod Sci. 2020 May; 27 (5):1129-1138 Epub 2020 Jan 06
    View PubMed
  27. Tumer G, Gniadek T, Baye J, Pena R, Warner P, Fung M, Beaudin L, Dunckley H, Gandhi M, Gathof B, Hsu S, Klohe E, Marcus N, Bamert R, Sims S, Takanashi M, Wendel S, Cohn CS, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet-refractory patients. Transfusion. 2020 Mar; 60 (3):488-497 Epub 2020 Jan 17
    View PubMed
  28. Zalpuri S, Romeijn B, Allara E, Goldman M, Kamel H, Gorlin J, Vassallo R, Gregoire Y, Goto N, Flanagan P, Speedy J, Buser A, Kutner JM, Magnussen K, Castren J, Culler L, Sussmann H, Prinsze FJ, Belanger K, Compernolle V, Tiberghien P, Cardenas JM, Gandhi MJ, West KA, Lee CK, James S, Wells D, Sutor LJ, Wendel S, Coleman M, Seltsam A, Roden K, Steele WR, Bohonek M, Alcantara R, Di Angelantonio E, van den Hurk K, BEST Collaborative Study Group. Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low-hemoglobin deferral rates: a BEST Collaborative study. Transfusion. 2020 Mar; 60 (3):544-552 Epub 2020 Feb 08
    View PubMed
  29. Choung RS, Mills JR, Snyder MR, Murray JA, Gandhi MJ. Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac disease. Hum Immunol. 2020 Feb - Mar; 81 (2-3):59-64 Epub 2020 Jan 28
    View PubMed
  30. Alexander MP, Bentall A, Aleff PCA, Gandhi MJ, Scott JP, Roden AC. Ultrastructural changes in pulmonary allografts with antibody-mediated rejection. J Heart Lung Transplant. 2020 Feb; 39 (2):165-175 Epub 2019 Dec 06
    View PubMed
  31. Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S. Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019 Sep; 25 (9):1875-1883 Epub 2019 May 11
    View PubMed
  32. Schinstock CA, Bentall AJ, Smith BH, Cornell LD, Everly M, Gandhi MJ, Stegall MD. Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies. Am J Transplant. 2019 Jun; 19 (6):1671-1683 Epub 2018 Dec 15
    View PubMed
  33. Schinstock CA, Dadhania DM, Everly MJ, Smith B, Gandhi M, Smith B, Farkash E, Sharma VK, Samaniego-Picota M, Stegall MD. Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study. Transpl Int. 2019 May; 32 (5):502-515 Epub 2019 Feb 08
    View PubMed
  34. Dukek BA, Zuccarelli MD, Wakefield LL, Kreuter JD, Gandhi MJ. HLA-B*45:22: a novel allele that differs from HLA-B*45:01:01 at several locations. HLA. 2019 Jan; 93 (1):49-50 Epub 2018 Dec 06
    View PubMed
  35. Ravindran A, Cortese C, Larsen CP, Wadei HM, Gandhi MJ, Cosio FG, Sethi S. Karyomegalic interstitial nephritis in a renal allograft. Am J Transplant. 2019 Jan; 19 (1):285-290 Epub 2018 Aug 20
    View PubMed
  36. Whitaker BI, Strong DM, Gandhi MJ, Petrisli E. Hemovigilance and the Notify Library. Immunohematology. 2019; 33 (4):159-164
    View PubMed
  37. Schinstock CA, Gandhi MJ. Maintaining the Health of the Renal Allograft: Laboratory and Histologic Monitoring After Kidney Transplantation. Clin Lab Med. 2018 Dec; 38 (4):607-621 Epub 2018 Oct 05
    View PubMed
  38. Hefazi M, Hogan WJ, Wakefield LL, Gandhi MJ. The association of de novo anti-HLA-DPB1 donor-specific antibody formation and primary graft failure after allogeneic hematopoietic cell transplantation. Hum Immunol. 2018 Dec; 79 (12):861-864 Epub 2018 Aug 22
    View PubMed
  39. Knauer R, Dukek BA, Kubat D, Kreuter JD, Gandhi MJ. Identifying a newly discovered HLA-C allele, HLA-C*02:138. HLA. 2018 Oct; 92 (4):253-254
    View PubMed
  40. Hefazi M, Langer KJ, Khera N, Adamski J, Roy V, Winters JL, Gastineau DA, Jacob EK, Kreuter JD, Gandhi MJ, Hogan WJ, Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions. Biol Blood Marrow Transplant. 2018 Sep; 24 (9):1906-1913 Epub 2018 Apr 18
    View PubMed
  41. Moyer AM, Hashmi SK, Kroning C, De Goey SR, Patnaik M, Litzow M, Gastineau DA, Hogan WJ, Jacob EK, Kreuter JD, Wakefield LL, Gandhi MJ. Does matching for SNPs in the MHC gamma block in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant improve outcomes? Hum Immunol. 2018 Jul; 79 (7):532-536 Epub 2018 Apr 13
    View PubMed
  42. Duellman PM, Schneider BA, Dukek BA, Wakefield LL, Gandhi MJ. Identifying a newly discovered HLA-C allele: HLA-C*07:607. HLA. 2018 May 7 Epub 2018 May 07
    View PubMed
  43. Cheungpasitporn W, Kremers WK, Lorenz E, Amer H, Cosio FG, Stegall MD, Gandhi MJ, Schinstock CA. De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection. Clin Transplant. 2018 Mar; 32 (3):e13194 Epub 2018 Feb 11
    View PubMed
  44. Gandhi MJ, Strong DM, Whitaker BI, Petrisli E. A brief overview of clinical significance of blood group antibodies. Immunohematology. 2018 Jan; 33 (1):4-6
    View PubMed
  45. Burgstaler EA, Duffy KJ, Gandhi MJ. Comparison of two double red cell collection settings on Fenwal Alyx apheresis instrument. J Clin Apher. 2017 Dec; 32 (6):392-396 Epub 2017 Feb 09
    View PubMed
  46. Juskewitch JE, Norgan AP, De Goey SR, Duellman PM, Wakefield LL, Gandhi MJ, Stubbs JR, Kreuter JD. How do I ... manage the platelet transfusion-refractory patient? Transfusion. 2017 Dec; 57 (12):2828-2835 Epub 2017 Sept 28
    View PubMed
  47. Whitaker BI, Strong DM, Gandhi MJ, Petrisli E. Hemovigilance and the Notify Library. Immunohematology. 2017 Dec; 33 (4):159-164
    View PubMed
  48. Moreno Gonzales MA, Mitema DG, Smith BH, Schinstock CA, Stegall MD, Wakefield LL, Henderson NA, DeGoey SR, Kreuter JD, Gandhi MJ. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies. Transplant Proc. 2017 Nov; 49 (9):2031-2035
    View PubMed
  49. Wong KL, Taner T, Smith BH, Kushwaha SS, Edwards BS, Gandhi MJ, Kremers WK, Daly RC, Pereira NL. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation. Circulation 2017 Oct 3; 136 (14):1350-1352
    View PubMed
  50. Schinstock CA, Gandhi M, Cheungpasitporn W, Mitema D, Prieto M, Dean P, Cornell L, Cosio F, Stegall M. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates. Transplantation. 2017 Oct; 101 (10):2429-2439
    View PubMed
  51. Gandhi MJ, Ferriola D, Lind C, Duke JL, Huynh A, Papazoglou A, Mackiewicz K, Christiansen M, Dong W, Hsu S, Thomas D, Schneider B, Pierce E, Kearns J, Kamoun M, Monos D, Askar M. Assessing a single targeted next generation sequencing for human leukocyte antigen typing protocol for interoperability, as performed by users with variable experience. Hum Immunol. 2017 Oct; 78 (10):642-648 Epub 2017 July 18
    View PubMed
  52. Fang H, King KS, Larson JJ, Snyder MR, Wu TT, Gandhi MJ, Murray JA. Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients. Aliment Pharmacol Ther. 2017 Oct; 46 (7):681-687 Epub 2017 Aug 07
    View PubMed
  53. Moyer AM, Hashmi SK, Kroning CM, Kremers WK, De Goey SR, Patnaik M, Litzow M, Gastineau DA, Hogan WJ, Jacob EK, Kreuter JD, Wakefield LL, Gandhi MJ. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant. Eur J Haematol. 2017 Sep; 99 (3):275-282 Epub 2017 July 21
    View PubMed
  54. Moreno Gonzales MA, Gandhi MJ, Schinstock CA, Moore NA, Smith BH, Braaten NY, Stegall MD. 32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody. Transplantation. 2017 Jun; 101 (6):1222-1227
    View PubMed
  55. Gandhi MJ, Ferriola D, Huang Y, Duke JL, Monos D. Targeted Next-Generation Sequencing for Human Leukocyte Antigen Typing in a Clinical Laboratory: Metrics of Relevance and Considerations for Its Successful Implementation. Arch Pathol Lab Med. 2017 Jun; 141 (6):806-812 Epub 2017 Feb 24
    View PubMed
  56. Dias AL, Hashmi S, Hogan W, Baig N, Wakefield L, Kreuter J, Gandhi MJ. The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection. Bone Marrow Transplant. 2017 Jun; 52 (6):902-904 Epub 2017 Feb 20
    View PubMed
  57. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant. 2016 Dec; 16 (12):3522-3531 Epub 2016 June 24
    View PubMed
  58. Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Muller CR, Fernandez-Vina MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research. Haematologica. 2016 Oct; 101 (10):1267-1274 Epub 2016 May 31
    View PubMed
  59. Burgstaler EA, Duffy KJ, Gandhi MJ. Double red blood cell collection: comparison of three apheresis systems. Transfusion. 2016 Sep; 56 (9):2362-7 Epub 2016 July 13
    View PubMed
  60. Schinstock CA, Gandhi MJ, Stegall MD. Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation. 2016 Aug; 100 (8):1619-28
    View PubMed
  61. Mir MA, Kapoor P, Kumar S, Pandey S, Dispenzieri A, Lacy MQ, Dingli D, Hogan W, Buadi F, Hayman S, Gandhi M, Gertz MA. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15 (6):349-357.e2 Epub 2015 Apr 02
    View PubMed
  62. Kattah A, Ayalon R, Beck LH Jr, Sethi S, Sandor DG, Cosio FG, Gandhi MJ, Lorenz EC, Salant DJ, Fervenza FC. Anti-phospholipase A(2) receptor antibodies in recurrent membranous nephropathy. Am J Transplant. 2015 May; 15 (5):1349-59 Epub 2015 Mar 12
    View PubMed
  63. Toy P, Bacchetti P, Grimes B, Gajic O, Murphy EL, Winters JL, Gropper MA, Hubmayr RD, Matthay MA, Wilson G, Koenigsberg M, Lee DC, Hirschler NV, Lowell CA, Schuller RM, Gandhi MJ, Norris PJ, Mair DC, Sanchez Rosen R, Looney MR. Recipient clinical risk factors predominate in possible transfusion-related acute lung injury. Transfusion. 2015 May; 55 (5):947-52 Epub 2014 Dec 08
    View PubMed
  64. Cornell LD, Schinstock CA, Gandhi MJ, Kremers WK, Stegall MD. Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year. Am J Transplant. 2015 May; 15 (5):1293-302 Epub 2015 Mar 02
    View PubMed
  65. Roden AC, Maleszewski JJ, Yi ES, Jenkins SM, Gandhi MJ, Scott JP, Aubry MC. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies. J Heart Lung Transplant. 2014 Dec; 33(12):1223-32. Epub 2014 Jun 18.
    View PubMed
  66. Bentall A, Tyan DB, Sequeira F, Everly MJ, Gandhi MJ, Cornell LD, Li H, Henderson NA, Raghavaiah S, Winters JL, Dean PG, Stegall MD. Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int. 2014 Dec; 27 (12):1235-43 Epub 2014 Aug 20
    View PubMed
  67. Bentall A, Herrera LP, Cornell LD, Gonzales MA, Dean PG, Park WD, Gandhi MJ, Winters JL, Stegall MD. Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation. Transplantation. 2014 Nov 27; 98 (10):1089-96
    View PubMed
  68. Li H, Stegall MD, Dean PG, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosberg CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M. Assessing the efficacy of kidney paired donation--performance of an integrated three-site program. Transplantation. 2014 Aug 15; 98 (3):300-5
    View PubMed
  69. Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL. The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation. 2014 Jul 27; 98 (2):229-38
    View PubMed
  70. Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P, Transfusion-Related Acute Lung Injury Study Group. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med. 2014 Jul; 42 (7):1676-87
    View PubMed
  71. Zand L, Lorenz EC, Cosio FG, Fervenza FC, Nasr SH, Gandhi MJ, Smith RJ, Sethi S. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol. 2014 May; 25 (5):1110-7 Epub 2013 Dec 19
    View PubMed
  72. Pidala J, Wang T, Haagenson M, Spellman SR, Askar M, Battiwalla M, Baxter-Lowe LA, Bitan M, Fernandez-Vina M, Gandhi M, Jakubowski AA, Maiers M, Marino SR, Marsh SG, Oudshoorn M, Palmer J, Prasad VK, Reddy V, Ringden O, Saber W, Santarone S, Schultz KR, Setterholm M, Trachtenberg E, Turner EV, Woolfrey AE, Lee SJ, Anasetti C. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood. 2013 Nov 21; 122: (22)3651-8.
    View PubMed
  73. Coburn JA, Vande Voort JL, Lahr BD, Van Dyke CT, Kroning CM, Wu TT, Gandhi MJ, Murray JA. Human leukocyte antigen genetics and clinical features of self-treated patients on a gluten-free diet. J Clin Gastroenterol. 2013 Nov-Dec; 47 (10):828-33
    View PubMed
  74. Gandhi MJ, Carrick DM, Jenkins S, De Goey S, Ploeger NA, Wilson GA, Lee JH, Winters JL, Stubbs JR, Toy P, Norris PJ, National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research TRALI Study and Retrovirus Epidemiology Donor Study-II. Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion. 2013 Sep; 53 (9):1940-7 Epub 2013 Jan 10
    View PubMed
  75. Shankar N, Daly R, Geske J, Kushwaha SK, Timmons M, Joyce L, Stulak J, Gandhi M, Kremers W, Park S, Pereira NL. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation. 2013 Aug 15; 96(3):324-30.
    View PubMed
  76. Dong M, Parsaik AK, Kremers W, Sun A, Dean P, Prieto M, Cosio FG, Gandhi MJ, Zhang L, Smyrk TC, Stegall MD, Kudva YC. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation. Am J Transplant. 2013 Apr; 13 (4):1019-1025 Epub 2013 Feb 22
    View PubMed
  77. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  78. Gandhi MJ, Degoey S, Falbo D, Jenkins S, Stubbs JR, Noreen H, Lorentzen DF, Lee J, Stegall M. Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay. Hum Immunol. 2013 Mar; 74 (3):310-7 Epub 2012 Dec 10
    View PubMed
  79. Askar M, Daghstani J, Thomas D, Leahy N, Dunn P, Claas F, Doran S, Saji H, Kanangat S, Karoichane M, Tambur A, Monos D, El-Khalifa M, Turner V, Kamoun M, Mustafa M, Ramon D, Gandhi M, Vernaza A, Gorodezky C, Wagenknecht D, Gautreaux M, Hajeer A, Kashi Z, Fernandez-Vina M. 16(th) IHIW: global distribution of extended HLA haplotypes. Int J Immunogenet. 2013 Feb; 40(1):31-8.
    View PubMed
  80. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95 (2):389-96
    View PubMed
  81. Schinstock C, Dean PG, Li H, Casey ET, Reddy KS, Khamash HA, Heilman RL, Mai ML, Taner CB, Kosbergl CL, Bakken LL, Wozniak EJ, Giles KL, Veal LA, Gandhi MJ, Cosio FG, Prieto M, Stegall MD. Desensitization in the era of kidney paired donation: the Mayo Foundation 3-site experience. Clin Transpl. 2013; 235-9.
    View PubMed
  82. Bentall A, Cornell LD, Gloor JM, Park WD, Gandhi MJ, Winters JL, Chedid MF, Dean PG, Stegall MD. Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am J Transplant. 2013 Jan; 13 (1):76-85 Epub 2012 Oct 16
    View PubMed
  83. Gandhi MJ, Duffy K, Benike M, Jenkins S, Stubbs JR. Effect of increasing hemoglobin cutoff in male donors and increasing interdonation interval in whole blood donors at a hospital-based blood donor center. Transfusion. 2012 Sep; 52 (9):1880-8 Epub 2012 Feb 08
    View PubMed
  84. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, Heimbach JK. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012 Jun; 12 (6):1504-10 Epub 2012 Mar 15
    View PubMed
  85. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA, TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757-67. Epub 2011 Nov 23.
    View PubMed
  86. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  87. Stegall MD, Diwan T, Raghavaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant. 2011 Nov; 11 (11):2405-13 Epub 2011 Sept 22
    View PubMed
  88. Jacob EK, De Goey SR, Gandhi MJ. Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol. 2011 Jul; 25(1):77-81. Epub 2011 May 23.
    View PubMed
  89. Jaben EA, Gandhi MJ. The post-platelet 100,000 count: effects of platelet collection and future. J Clin Apher. 2011; 26(1):53-5. Epub 2010 Nov 9
    View PubMed
  90. Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol. 2011 Jan; 230 (1-2):130-4 Epub 2010 Nov 06
    View PubMed
  91. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori VM, Roback JD. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion. 2010 Jun; 50 (6):1370-83 Epub 2010 Mar 19
    View PubMed
  92. Gloor JM, Winters JL, Cornell LD, Fix LA, DeGoey SR, Knauer RM, Cosio FG, Gandhi MJ, Kremers W, Stegall MD. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant. 2010 Mar; 10 (3):582-9 Epub 2010 Jan 29
    View PubMed
  93. Grafft CA, Cornell LD, Gloor JM, Cosio FG, Gandhi MJ, Dean PG, Stegall MD, Amer H. Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant. 2010 Jan; 25 (1):307-10 Epub 2009 Oct 20
    View PubMed
  94. Jacob EK, Burgstaler EA, Winters JL, Stubbs JR, Gandhi MJ. Transfusion medicine illustrated. Thrombus formation during platelet donation. Transfusion. 2009 Oct; 49(10):2021.
    View PubMed
  95. Johnson HJ, Gandhi MJ, Shafizadeh E, Langer NB, Pierce EL, Paw BH, Gilligan DM, Drachman JG. In vivo inactivation of MASTL kinase results in thrombocytopenia. Exp Hematol. 2009 Aug; 37(8):901-8. Epub 2009 May 19.
    View PubMed
  96. Jacob EK, Emery RL, Orrock JM, van Buskirk CM, Gandhi MJ. Filter failures with sickling hemoglobin. Transfusion. 2009 Aug; 49(8):1535-6.
    View PubMed
  97. Burns JM, Cornell LD, Perry DK, Pollinger HS, Gloor JM, Kremers WK, Gandhi MJ, Dean PG, Stegall MD. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant. 2008 Dec; 8 (12):2684-94 Epub 2008 Oct 24
    View PubMed
  98. Gandhi MJ, Narra VR, Brown JJ, Guo A, Grosu DS, Parvin CA, Scott MG. Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference. AJR Am J Roentgenol. 2008 Mar; 190(3):W213-7.
    View PubMed
  99. Gandhi MJ, Strong DM. Donor Derived Malignancy following Transplantation, A Review Cell and Tissue Transplant [Epub] 2007 Apr 12.
  100. Gandhi MJ, Shapiro E, Emmert L, Strong DM, Price TH. Prestorage leukoreduction does not increase hemolysis of stored red cell concentrates. Transfus Apher Sci. 2007 Feb; 36(1):17-22. Epub 2007 Jan 23.
    View PubMed
  101. Gandhi MJ, Pierce RA, Zhang L, Moon MR, Despotis GJ, Moazami N. Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg. 2007; 2:32. Epub 2007 Jul 06.
    View PubMed
  102. Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG. Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation. Exp Hematol. 2005 Oct; 33(10):1215-21.
    View PubMed
  103. Gandhi MJ, Strong DM. Cardiovascular tissues for transplantation. Clin Lab Med. 2005 Sep; 25(3):571-85.
    View PubMed
  104. Gandhi MJ, Drachman JG, Reems JA, Thorning D, Lannutti BJ. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis. 2005 Jul-Aug; 35(1):70-3.
    View PubMed
  105. Heller PG, Glembotsky AC, Gandhi MJ, Cummings CL, Pirola CJ, Marta RF, Kornblihtt LI, Drachman JG, Molinas FC. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood. 2005 Jun 15; 105(12):4664-70. Epub 2005 Mar 01.
    View PubMed
  106. Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood. 2005 May 15; 105(10):3875-8.
    View PubMed
  107. Luthi JN, Gandhi MJ, Drachman JG. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome(WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp Hematol. 2003 Feb; 31(2):150-8.
    View PubMed
  108. Gandhi MJ, Cummings CL, Drachman JG. FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10. Hum Hered. 2003; 55(1):66-70.
    View PubMed
  109. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 2001 Nov 1; 98(9):2681-8.
    View PubMed
  110. Gandhi MJ, Yang GG, McMahon BJ, Vyas GN. Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted. Transfusion. 2000 Aug; 40(8):910-6.
    View PubMed
  111. Gandhi MJ, Boyd MR, Yi L, Yang GG, Vyas GN. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N). Dev Biol (Basel). 2000; 102: 141-8.
    View PubMed